|
US10004684B2
(en)
|
2001-02-14 |
2018-06-26 |
Gw Pharma Limited |
Pharmaceutical formulations
|
|
GB2377633A
(en)
*
|
2001-05-11 |
2003-01-22 |
Gw Pharmaceuticals Ltd |
Pharmaceutical compositions comprising the cannabinoids THC and CBD
|
|
NZ527289A
(en)
*
|
2001-02-14 |
2005-05-27 |
Gw Pharma Ltd |
Lipophilic medicaments and their administration via mucosal surfaces
|
|
WO2003063847A1
(en)
*
|
2002-02-01 |
2003-08-07 |
Gw Pharma Limited |
Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
|
|
GB0202385D0
(en)
*
|
2002-02-01 |
2002-03-20 |
Gw Pharma Ltd |
Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions
|
|
IL148244A0
(en)
|
2002-02-19 |
2002-09-12 |
Yissum Res Dev Co |
Anti-nausea and anti-vomiting activity of cannabidiol compounds
|
|
CA2455129C
(en)
*
|
2002-08-14 |
2013-10-22 |
Gw Pharma Limited |
Improvements in the extraction of pharmaceutically active components from plant materials
|
|
GB2393182B
(en)
*
|
2002-09-23 |
2007-03-14 |
Gw Pharma Ltd |
Method of preparing cannabidiol from plant material
|
|
GB2394894B
(en)
*
|
2002-11-04 |
2005-08-31 |
G W Pharma Ltd |
New use for pharmaceutical composition
|
|
US20040248970A1
(en)
*
|
2003-04-10 |
2004-12-09 |
Webster G.R. Barrie |
CBD-delta8-THC composition
|
|
US7320805B2
(en)
*
|
2003-10-01 |
2008-01-22 |
Institut National De La Sante Et De La Recherche Medicale |
CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel artifibrogenic pathway in the liver
|
|
GB2414933B
(en)
*
|
2004-06-08 |
2009-07-15 |
Gw Pharma Ltd |
Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
|
|
US20060247321A1
(en)
*
|
2005-05-02 |
2006-11-02 |
June Chen |
Abnormal Cannabidiols as agents useful in combination therapy for lowering intraocular pressure
|
|
WO2006024958A2
(en)
*
|
2004-08-09 |
2006-03-09 |
Novimmune S.A. |
Cannabinoid compositions and methods of use thereof
|
|
TWI436991B
(en)
|
2004-11-22 |
2014-05-11 |
Euro Celtique Sa |
Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
|
|
CN101132781A
(en)
*
|
2004-12-09 |
2008-02-27 |
茵西斯医疗公司 |
Room-temperature stable dronabinol formulations
|
|
TWI366460B
(en)
|
2005-06-16 |
2012-06-21 |
Euro Celtique Sa |
Cannabinoid active pharmaceutical ingredient for improved dosage forms
|
|
GB2431105A
(en)
*
|
2005-10-12 |
2007-04-18 |
Gw Pharma Ltd |
Cannabinoids for the treatment of pulmonary disorders
|
|
ATE504836T1
(en)
|
2005-10-31 |
2011-04-15 |
Janssen Pharmaceutica Nv |
METHOD FOR IDENTIFYING TRPV2 MODULATORS
|
|
GB2432312A
(en)
*
|
2005-11-01 |
2007-05-23 |
Gw Pharma Ltd |
Pharmaceutical compositions for the treatment of pain
|
|
EP1903866B1
(en)
*
|
2005-11-07 |
2016-04-06 |
Murty Pharmaceuticals, Inc. |
Improved delivery of tetrahydrocannabinol
|
|
GB2434312B
(en)
*
|
2006-01-18 |
2011-06-29 |
Gw Pharma Ltd |
Cannabinoid-containing plant extracts as neuroprotective agents
|
|
GB2439393B
(en)
*
|
2006-06-23 |
2011-05-11 |
Gw Pharma Ltd |
Cannabinoids for use in the treatment of neuropathic pain
|
|
US20080112895A1
(en)
*
|
2006-08-04 |
2008-05-15 |
Insys Therapeutics Inc. |
Aqueous dronabinol formulations
|
|
PL2061427T3
(en)
*
|
2006-09-15 |
2011-12-30 |
Echo Pharmaceuticals Bv |
Granulate containing a pharmaceutically active substance and an emulsifier and method for its manufacture
|
|
AU2007295179B2
(en)
|
2006-09-15 |
2013-05-30 |
Echo Pharmaceuticals B.V. |
Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
|
|
GB2448535A
(en)
*
|
2007-04-19 |
2008-10-22 |
Gw Pharma Ltd |
New use for cannabinoid-containing plant extracts
|
|
US9084771B2
(en)
|
2007-05-17 |
2015-07-21 |
Sutter West Bay Hospitals |
Methods and compositions for treating cancer
|
|
GB2450741A
(en)
*
|
2007-07-05 |
2009-01-07 |
Gw Pharma Ltd |
Cannabinoid containing plant extracts in the treatment of inflammatory bowel disease
|
|
WO2009020666A1
(en)
*
|
2007-08-06 |
2009-02-12 |
Insys Therapeutics Inc. |
Oral cannabinoid liquid formulations and methods of treatment
|
|
DE102007046086A1
(en)
|
2007-09-26 |
2009-04-09 |
Heinz Prof. Dr. Letzel |
Plant extract from THC-poor cannabis for the treatment of diseases
|
|
GB2475183B
(en)
*
|
2008-06-04 |
2011-11-23 |
Gw Pharma Ltd |
Cannabinoids in combination with non-cannabinoid chemotherapeutic agent that are selective estrogen receptor modulators
|
|
GB2471987B
(en)
|
2008-06-04 |
2012-02-22 |
Gw Pharma Ltd |
Anti-tumoural effects of cannabinoid combinations
|
|
KR101048594B1
(en)
|
2009-05-04 |
2011-07-12 |
영남대학교 산학협력단 |
Pharmaceutical composition containing cannabinoid derivatives that inhibit angiogenesis and cancer growth
|
|
US20110038915A1
(en)
*
|
2009-08-14 |
2011-02-17 |
Eduardo Jose Gonzalez |
Chewing Gum Formula for Enhancing Psycho-Spirituality
|
|
GB2478595B
(en)
|
2010-03-12 |
2018-04-04 |
Gw Pharma Ltd |
Phytocannabinoids in the treatment of glioma
|
|
MX2013005564A
(en)
*
|
2010-11-18 |
2014-03-12 |
Pier Pharmaceuticals |
Low dose cannabinoid medicaments.
|
|
FR2973706B1
(en)
*
|
2011-04-06 |
2016-05-20 |
Guyen Gerard Duc N |
ESSENTIAL PHYTO-CONCENTRATE COMPOSITION ANTISPASMODIC DISCOVERY AND MUSCLE COMFORT
|
|
US8642645B2
(en)
*
|
2011-05-20 |
2014-02-04 |
Brooks Kelly Research, LLC. |
Pharmaceutical composition comprising Cannabinoids
|
|
GB2491118B
(en)
|
2011-05-20 |
2015-12-30 |
Otsuka Pharma Co Ltd |
Cannabinoids for use in the treatment of neuropathic pain
|
|
GB201111261D0
(en)
|
2011-07-01 |
2011-08-17 |
Gw Pharma Ltd |
Cannabinoids for use in the treatment of neuro-degenerative diseases or disorders
|
|
US8758826B2
(en)
*
|
2011-07-05 |
2014-06-24 |
Wet Inc. |
Cannabinoid receptor binding agents, compositions, and methods
|
|
EP2609912A1
(en)
*
|
2011-12-30 |
2013-07-03 |
Deva Holding Anonim Sirketi |
Pharmaceutical combination of fingolimod and nabiximols
|
|
GB2516814B
(en)
|
2013-06-19 |
2016-08-31 |
Otsuka Pharma Co Ltd |
Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
|
|
ES2547354T3
(en)
*
|
2013-09-03 |
2015-10-05 |
Symrise Ag |
Mixtures of cannabinoid compounds, their preparation and use
|
|
CA2930266A1
(en)
*
|
2013-11-11 |
2015-05-14 |
The Werc Shop, LLC |
Solvent-free processing, system and methods
|
|
US9380813B2
(en)
|
2014-02-11 |
2016-07-05 |
Timothy McCullough |
Drug delivery system and method
|
|
US9220294B2
(en)
|
2014-02-11 |
2015-12-29 |
Timothy McCullough |
Methods and devices using cannabis vapors
|
|
US10821240B2
(en)
|
2014-02-11 |
2020-11-03 |
Vapor Cartridge Technology Llc |
Methods and drug delivery devices using cannabis
|
|
US11331279B2
(en)
*
|
2014-05-29 |
2022-05-17 |
Radius Pharmaceuticals, Inc. |
Stable cannabinoid formulations
|
|
US11911361B2
(en)
|
2014-05-29 |
2024-02-27 |
Radius Pharmaceuticals, Inc. |
Stable cannabinoid formulations
|
|
US20160271252A1
(en)
*
|
2014-05-29 |
2016-09-22 |
Insys Development Company, Inc. |
Stable cannabinoid formulations
|
|
CA2953684C
(en)
|
2014-06-27 |
2023-01-03 |
Kenton L. Crowley |
Buccal and sublingual cannabinoid formulations and method of making the same
|
|
EP3193862B1
(en)
*
|
2014-09-16 |
2023-10-18 |
Igc Pharma Ip, Llc |
Topical cannabinoid composition for treating arthritic pain
|
|
EP3209312A1
(en)
|
2014-10-21 |
2017-08-30 |
United Cannabis Corp. |
Cannabis extracts and methods of preparing and using same
|
|
CN104277917B
(en)
*
|
2014-10-24 |
2018-02-09 |
汉康(云南)生物科技有限公司 |
A kind of industrial hemp method of extraction of essential oil and its extraction equipment rich in cannabidiol
|
|
WO2016118391A1
(en)
|
2015-01-25 |
2016-07-28 |
India Globalization Capital, Inc. |
Composition and method for treating seizure disorders
|
|
US20160331720A1
(en)
*
|
2015-05-15 |
2016-11-17 |
Andrew David Hospodor |
Scaleable cannabinoid treatment regimine and medicinal formulations
|
|
CA2986268C
(en)
|
2015-05-28 |
2024-01-02 |
Insys Development Company, Inc. |
Stable cannabinoid formulations
|
|
WO2016205923A1
(en)
*
|
2015-06-25 |
2016-12-29 |
Compressed Perforated Puck Technologies Inc. |
Ingestible plant source pill and method
|
|
MX2018000844A
(en)
*
|
2015-07-22 |
2018-07-06 |
Phytopharma Int Ltd |
Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby.
|
|
US10596159B2
(en)
|
2015-08-12 |
2020-03-24 |
India Globalization Capital, Inc. |
Method and composition for treating cachexia and eating disorders
|
|
BR102015024165A2
(en)
*
|
2015-09-18 |
2017-03-28 |
Prati Donaduzzi & Cia Ltda |
oral pharmaceutical composition comprising cannabinoid, process for its preparation and use
|
|
US10499584B2
(en)
|
2016-05-27 |
2019-12-10 |
New West Genetics |
Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
|
|
EP3471746A4
(en)
|
2016-06-15 |
2020-02-26 |
India Globalization Capital, Inc. |
Method and composition for treating seizure disorders
|
|
IL248149B
(en)
|
2016-09-29 |
2020-03-31 |
Garti Nissim |
Dilutable formulations of cannbinoids and processes for their preparation
|
|
IL248150B
(en)
*
|
2016-09-29 |
2018-05-31 |
Garti Nissim |
Method for selective extraction of cannabinoids from a plant source
|
|
IL248148B
(en)
|
2016-09-29 |
2021-09-30 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Method for extraction of an agent from a plant source
|
|
US10239808B1
(en)
|
2016-12-07 |
2019-03-26 |
Canopy Holdings, LLC |
Cannabis extracts
|
|
US10933016B2
(en)
|
2017-02-24 |
2021-03-02 |
Trinidad Consulting, Llc |
Compositions and methods for oral administration of cannabinoids and terpenoids
|
|
US20180343812A1
(en)
*
|
2017-05-31 |
2018-12-06 |
Insectergy, Llc |
Cannabis farming systems and methods
|
|
CN109200046A
(en)
*
|
2017-07-04 |
2019-01-15 |
汉义生物科技（北京）有限公司 |
Application of the Cannabinoids compound in treatment neurodermatitis
|
|
US10272360B2
(en)
|
2017-08-05 |
2019-04-30 |
Priya Naturals, Inc. |
Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
|
|
AU2018101357B4
(en)
*
|
2017-09-15 |
2022-03-17 |
Zelira Therapeutics Operations Pty Ltd |
Composition and method for treating autism
|
|
WO2019073127A2
(en)
*
|
2017-10-12 |
2019-04-18 |
Nguyen Gerard |
Phyto-concentrated composition and uses thereof
|
|
US20190183849A1
(en)
*
|
2017-10-21 |
2019-06-20 |
Alexander Kariman |
Compound and method for treatment of diseases and disorders
|
|
US12090129B2
(en)
|
2017-11-22 |
2024-09-17 |
Axcess Global Sciences, Llc |
Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
|
|
US10925843B2
(en)
|
2018-04-18 |
2021-02-23 |
Axcess Global Sciences, Llc |
Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
|
|
US11944598B2
(en)
|
2017-12-19 |
2024-04-02 |
Axcess Global Sciences, Llc |
Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
|
|
CA3089994A1
(en)
|
2018-01-31 |
2019-08-08 |
Canopy Holdings, LLC |
Hemp powder
|
|
US11806324B2
(en)
|
2018-04-18 |
2023-11-07 |
Axcess Global Sciences, Llc |
Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
|
|
US20200061023A1
(en)
*
|
2018-08-27 |
2020-02-27 |
Axcess Global Sciences, Llc |
Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
|
|
WO2019227167A1
(en)
*
|
2018-06-01 |
2019-12-05 |
The University Of Sydney |
Compositions and treatments
|
|
WO2019237156A1
(en)
*
|
2018-06-15 |
2019-12-19 |
CannPal Animal Therapeutics Limited |
Cannabinoid composition and methods of treatment using the same
|
|
BR112020026393A2
(en)
*
|
2018-07-11 |
2021-03-23 |
Aquanova Ag |
solubilized with curcumin and at least cannabinoid thc as another active substance
|
|
US11504416B2
(en)
|
2018-09-04 |
2022-11-22 |
Paw Power, Inc. |
Formulation with cannabinoids
|
|
US11254633B2
(en)
|
2018-10-05 |
2022-02-22 |
Jonas Alcirdas Navickas |
Cannabis thin layer decarboxylation
|
|
PE20211198A1
(en)
*
|
2018-10-10 |
2021-07-01 |
Tilray Inc |
METHODS AND FORMULATIONS TO TREAT CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
|
|
US11040932B2
(en)
|
2018-10-10 |
2021-06-22 |
Treehouse Biotech, Inc. |
Synthesis of cannabigerol
|
|
MX2021005573A
(en)
*
|
2018-11-12 |
2021-07-02 |
Hanyi Bio Tech Beijing Co Ltd |
Use of cannabinoid compound in neurodermatitis treatment.
|
|
US11950616B2
(en)
|
2019-06-21 |
2024-04-09 |
Axcess Global Sciences, Llc |
Non-vasoconstricting energy-promoting compositions containing ketone bodies
|
|
WO2021055079A1
(en)
|
2019-09-16 |
2021-03-25 |
Vapor Cartridge Technology Llc |
Drug delivery system with stackable substrates
|
|
US12016829B2
(en)
|
2019-10-11 |
2024-06-25 |
Pike Therapeutics Inc. |
Pharmaceutical composition and method for treating seizure disorders
|
|
US20220396540A1
(en)
*
|
2019-11-11 |
2022-12-15 |
Natural Extraction Systems, LLC |
Methods to separate cannabinoids from impurities by crystallization
|
|
WO2021159058A1
(en)
*
|
2020-02-08 |
2021-08-12 |
Diverse Biotech, Inc. |
Novel cannabinoids formulations and their use for the treatment of acute flaccid myelitis
|
|
US20220317097A1
(en)
*
|
2021-04-05 |
2022-10-06 |
Grant Kraus |
Atmospheric Triphasic Chromatography (ATC) method
|
|
CA3217137A1
(en)
|
2021-04-29 |
2022-11-03 |
Christopher Adair |
Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof
|